These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30460578)

  • 1. Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population.
    van Waateringe RP; Fokkens BT; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Smit AJ; Lutgers HL; Wolffenbuttel BHR
    Diabetologia; 2019 Feb; 62(2):269-280. PubMed ID: 30460578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
    Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR
    BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin autofluorescence predicts cardiovascular mortality in patients on chronic hemodialysis.
    Kimura H; Tanaka K; Kanno M; Watanabe K; Hayashi Y; Asahi K; Suzuki H; Sato K; Sakaue M; Terawaki H; Nakayama M; Miyata T; Watanabe T
    Ther Apher Dial; 2014 Oct; 18(5):461-7. PubMed ID: 24456287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: The LifeLines Cohort Study.
    Fokkens BT; van Waateringe RP; Mulder DJ; Wolffenbuttel BHR; Smit AJ
    Diabetes Metab; 2018 Nov; 44(5):424-430. PubMed ID: 29097003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes.
    Christensen RH; von Scholten BJ; Hansen CS; Jensen MT; Vilsbøll T; Rossing P; Jørgensen PG
    Cardiovasc Diabetol; 2019 Aug; 18(1):114. PubMed ID: 31470858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.
    Guzder RN; Gatling W; Mullee MA; Byrne CD
    Diabetologia; 2006 Jan; 49(1):49-55. PubMed ID: 16341841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.
    Brownrigg JR; de Lusignan S; McGovern A; Hughes C; Thompson MM; Ray KK; Hinchliffe RJ
    Heart; 2014 Dec; 100(23):1837-43. PubMed ID: 25095826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in 'at risk' individuals with normoglycaemia? Results from the ADDITION-Denmark cluster-randomised controlled trial.
    Simmons RK; Bruun NH; Witte DR; Borch-Johnsen K; Jørgensen ME; Sandbæk A; Lauritzen T
    Diabetologia; 2017 Jun; 60(6):1016-1021. PubMed ID: 28280901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
    Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
    Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
    Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Body Mass Index with the Risk of Incident Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality: A Community-Based Prospective Study.
    Bae JC; Cho NH; Kim JH; Hur KY; Jin SM; Lee MK
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):416-424. PubMed ID: 32615726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
    Hanssen NMJ; Westerink J; Scheijen JLJM; van der Graaf Y; Stehouwer CDA; Schalkwijk CG;
    Diabetes Care; 2018 Aug; 41(8):1689-1695. PubMed ID: 29784769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence is a predictor of cardiovascular disease in chronic kidney disease patients.
    Furuya F; Shimura H; Takahashi K; Akiyama D; Motosugi A; Ikegishi Y; Haraguchi K; Kobayashi T
    Ther Apher Dial; 2015 Feb; 19(1):40-4. PubMed ID: 25545539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.
    Bonora E; Targher G; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Gemma L; Santi L; Bonadonna RC; Muggeo M
    Diabet Med; 2004 Jan; 21(1):52-8. PubMed ID: 14706054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High risk for cardiovascular disease in Chinese type 2 diabetic patients with major depression--a 7-year prospective analysis of the Hong Kong Diabetes Registry.
    Ting RZ; Lau ES; Ozaki R; Lau WW; Kong AP; Luk AO; Chow CC; Ma RC; Wing YK; Chan JC; So WY
    J Affect Disord; 2013 Jul; 149(1-3):129-35. PubMed ID: 23399477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
    Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate.
    Hulman A; Vistisen D; Glümer C; Bergman M; Witte DR; Færch K
    Diabetologia; 2018 Jan; 61(1):101-107. PubMed ID: 28983719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Diabetologia; 2017 Oct; 60(10):1883-1891. PubMed ID: 28681124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.
    Anand SS; Dagenais GR; Mohan V; Diaz R; Probstfield J; Freeman R; Shaw J; Lanas F; Avezum A; Budaj A; Jung H; Desai D; Bosch J; Yusuf S; Gerstein HC;
    Eur J Prev Cardiol; 2012 Aug; 19(4):755-64. PubMed ID: 21551215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.